| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 646 companies in the Biotechnology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | PRQR Proqr Therapeutics N.V. | Filius Bart | Director | Buy | 150,000 | $1.72 | $257,925.00 | +100.0% | - | - | |
| Jul 17, 2026 | FULC Fulcrum Therapeutics, Inc. | Tang Kevin85 | 10% Owner | Buy | 167,616 | $3.55 | $594,675.16 | +1.2% | - | - | |
| Jul 17, 2026 | ARTV Artiva Biotherapeutics, Inc. | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 160,354 | $8.93 | $1,432,118.86 | +0.5% | - | - | |
| Jul 17, 2026 | IMA Imagenebio, Inc. | Lally Robert B | Principal Accounting Officer | Sell | 3,196 | $5.42 | $17,334.00 | -2.8% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Lillie James Woodruff | Chief Scientific Officer | Sell | 18,267 | $36.88 | $673,636.18 | -1.1% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Gillis Jonathan | CAO And Interim CFO | Sell | 36,979 | $37.12 | $1,372,668.01 | -3.2% | - | - | |
| Jul 17, 2026 | MNKD Mannkind Corporation | Binder Steven B.66 | Director | Sell | 52,485 | $4.06 | $213,089.10 | -6.0% | - | - | |
| Jul 17, 2026 | MNKD Mannkind Corporation | Thomson David62 | EVP Genl Counsel &Secretary | Sell | 24,109 | $4.05 | $97,641.45 | -2.9% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Kreitzer Anatol | Chief Discovery Officer | Sell | 36,284 | $37.09 | $1,345,893.62 | -2.7% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Foff Erin Pennock | Chief Medical Officer | Sell | 47,158 | $36.78 | $1,734,490.12 | -1.6% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Hanson Kristopher | General Counsel | Sell | 16,508 | $36.82 | $607,870.19 | -1.5% | - | - | |
| Jul 17, 2026 | MPLT Maplight Therapeutics, Inc. | Kroeger Christopher A. | Chief Executive Officer | Sell | 147,639 | $36.87 | $5,443,721.84 | -1.6% | - | - | |
| Jul 16, 2026 | CBIO Crescent Biopharma, Inc. | Fairmount Funds Management LLC74 | Director, 10% Owner | Buy | 853,450 | $14.50 | $12,375,025.00 | +31.1% | - | - | |
| Jul 16, 2026 | ADPT Adaptive Biotechnologies Corporation | Bobulsky Susan | Chief Commercial Officer, Mrd | Sell | 5,000 | $23.00 | $115,000.00 | -1.2% | - | - | |
| Jul 16, 2026 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | 10% Owner | Sell | 10 | $13.73 | $137.30 | - | - | - | |
| Jul 16, 2026 | BEIGF Beone Medicines AG | Oyler John59 | Chief Executive Officer | Sell | 283,154 | $315.56 | $89,351,597.71 | -20.2% | - | - | |
| Jul 16, 2026 | BOLD Boundless Bio, Inc. | Tang Kevin85 | 10% Owner | Buy | 63,969 | $2.43 | $155,645.58 | +0.8% | - | - | |
| Jul 15, 2026 | VANI Vivani Medical, Inc. | Williams Gregg75 | Director, 10% Owner | Buy | 793,650 | $1.26 | $999,999.00 | +2.2% | - | - | |
| Jul 15, 2026 | CORT Corcept Therapeutics Incorporated | Wilson James N | Director | Sell | 10,000 | $88.30 | $882,985.62 | -0.2% | - | - | |
| Jul 15, 2026 | ANIX Anixa Biosciences, Inc. | Titterton Lewis H Jr65 | Director | Buy | 2,797 | $3.28 | $9,174.16 | +0.3% | - | - | |
| Jul 15, 2026 | ADPT Adaptive Biotechnologies Corporation | Lo Francis78 | Chief People Officer | Sell | 105,762 | $22.59 | $2,389,163.58 | -31.4% | - | - | |
| Jul 15, 2026 | MLTX Moonlake Immunotherapeutics | Reich Kristian78 | Chief Scientific Officer | Sell | 16,105 | $20.01 | $322,261.05 | -0.6% | - | - | |
| Jul 15, 2026 | ORKA Oruka Therapeutics, Inc. | Goncalves Joana89 | Chief Medical Officer | Sell | 7,000 | $86.28 | $603,937.77 | -4.7% | - | - | |
| Jul 15, 2026 | SEPN Septerna, Inc. | Bhatt Elizabeth | President And COO | Sell | 4,000 | $33.99 | $135,974.00 | -2.2% | - | - | |
| Jul 15, 2026 | CORT Corcept Therapeutics Incorporated | Mokari Atabak | Chief Financial Officer | Sell | 40,000 | $87.71 | $3,508,277.12 | -28.5% | - | - |